282 related articles for article (PubMed ID: 20932192)
21. Relationship between glutathione S-transferase P1 polymorphisms and chronic obstructive pulmonary disease in a Tunisian population.
Lakhdar R; Denden S; Knani J; Leban N; Daimi H; Hassine M; Lefranc G; Ben Chibani J; Haj Khelil A
Genet Mol Res; 2010 May; 9(2):897-907. PubMed ID: 20467983
[TBL] [Abstract][Full Text] [Related]
22. Oxidative Stress and Genetic Variants of Xenobiotic-Metabolising Enzymes Associated with COPD Development and Severity in Serbian Adults.
Malic Z; Topic A; Francuski D; Stankovic M; Nagorni-Obradovic L; Markovic B; Radojkovic D
COPD; 2017 Feb; 14(1):95-104. PubMed ID: 27421065
[TBL] [Abstract][Full Text] [Related]
23. [Study on the relationship between EPHX1 gene polymorphism and antioxidant capacity in patients with chronic obstructive pulmonary disease].
Luo Y; Dai LM; Jia M; Zhao ZH; Hu CM; Qi WY; Zhang JQ
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):760-764. PubMed ID: 31594110
[No Abstract] [Full Text] [Related]
24. Lung cancer susceptibility in relation to combined polymorphisms of microsomal epoxide hydrolase and glutathione S-transferase P1.
To-Figueras J; Gené M; Gómez-Catalán J; Piqué E; Borrego N; Corbella J
Cancer Lett; 2001 Nov; 173(2):155-62. PubMed ID: 11597790
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in the microsomal epoxide hydrolase gene: role in lung cancer susceptibility and prognosis.
Erkisi Z; Yaylim-Eraltan I; Turna A; Görmüs U; Camlica H; Isbir T
Tumori; 2010; 96(5):756-63. PubMed ID: 21302624
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM
Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365
[TBL] [Abstract][Full Text] [Related]
27. Lack of association between glutathione S-transferase P1 polymorphism and COPD in Koreans.
Yim JJ; Yoo CG; Lee CT; Kim YW; Han SK; Shim YS
Lung; 2002; 180(2):119-25. PubMed ID: 12172904
[TBL] [Abstract][Full Text] [Related]
28. EPHX1 Y113H polymorphism is associated with increased risk of chronic obstructive pulmonary disease in Kazakhstan population.
Akparova A; Abdrakhmanova B; Banerjee N; Bersimbaev R
Mutat Res Genet Toxicol Environ Mutagen; 2017 Apr; 816-817():1-6. PubMed ID: 28464990
[TBL] [Abstract][Full Text] [Related]
29. Correlation of EPHX1, GSTP1, GSTM1, and GSTT1 genetic polymorphisms with antioxidative stress markers in chronic obstructive pulmonary disease.
Lakhdar R; Denden S; Mouhamed MH; Chalgoum A; Leban N; Knani J; Lefranc G; Miled A; Ben Chibani J; Khelil AH
Exp Lung Res; 2011 May; 37(4):195-204. PubMed ID: 21309732
[TBL] [Abstract][Full Text] [Related]
30. Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1.
Yim JJ; Park GY; Lee CT; Kim YW; Han SK; Shim YS; Yoo CG
Thorax; 2000 Feb; 55(2):121-5. PubMed ID: 10639528
[TBL] [Abstract][Full Text] [Related]
31. EPHX1 polymorphisms, COPD and asthma in 47,000 individuals and in meta-analysis.
Lee J; Nordestgaard BG; Dahl M
Eur Respir J; 2011 Jan; 37(1):18-25. PubMed ID: 20516053
[TBL] [Abstract][Full Text] [Related]
32. hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease.
Yang SF; Xu YJ; Xie JG; Zhang ZX
Chin Med J (Engl); 2009 Apr; 122(8):960-6. PubMed ID: 19493423
[TBL] [Abstract][Full Text] [Related]
33. EPOXID HYDROLASE SINGLE GENE POLYMORPHISM (RS1051740) AND SEVERITY OF CHRONIC OBSTRUCTIVE DISEASE.
Antonova I; Gridnyev O; Galchinskaya V
Wiad Lek; 2022; 75(11 pt 2):2779-2784. PubMed ID: 36591768
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms of microsomal epoxide hydrolase and glutathione S-transferase P1 in a male Turkish population.
Ada AO; Suzen HS; Iscan M
Int J Toxicol; 2007; 26(1):41-6. PubMed ID: 17365145
[TBL] [Abstract][Full Text] [Related]
35. EPHX1 gene polymorphisms in alcohol dependence and their distribution among the Indian populations.
Bhaskar LV; Thangaraj K; Patel M; Shah AM; Gopal K; Saikrishna L; Tamang R; Singh L; Rao VR
Am J Drug Alcohol Abuse; 2013 Jan; 39(1):16-22. PubMed ID: 22257321
[TBL] [Abstract][Full Text] [Related]
36. Effect of N-acetylcysteine in COPD patients with different microsomal epoxide hydrolase genotypes.
Zhang JQ; Zhang JQ; Liu H; Zhao ZH; Fang LZ; Liu L; Fu WP; Shu JK; Feng JG; Dai LM
Int J Chron Obstruct Pulmon Dis; 2015; 10():917-23. PubMed ID: 25999707
[TBL] [Abstract][Full Text] [Related]
37. Exploration of association between EPHX1 and chronic obstructive pulmonary disease on the basis of combined data mining.
An L; Xia H; Zhou P; Hua L
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173271
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of association between gene polymorphisms of microsomal epoxide hydrolase (EPHX1) and infant birthweight].
Wu D; Zhang XQ; Yang F; Hong XM; Ju F; Chen DF
Yi Chuan Xue Bao; 2001; 28(7):595-600. PubMed ID: 11480169
[TBL] [Abstract][Full Text] [Related]
39. Microsomal epoxide hydrolase polymorphisms, cigarette smoking and prostate cancer risk in the Slovak population.
Sivonova MK; Dobrota D; Matakova T; Dusenka R; Grobarcikova S; Habala V; Salagovic J; Tajtakova M; Pidanicova A; Valansky L; Lachvacs L; Kliment J; Nagy V; Kliment J
Neoplasma; 2012; 59(1):79-84. PubMed ID: 22103900
[TBL] [Abstract][Full Text] [Related]
40. Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk.
Liu F; Yuan D; Wei Y; Wang W; Yan L; Wen T; Xu M; Yang J; Li B
PLoS One; 2012; 7(8):e43821. PubMed ID: 22928041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
